The entry page for asbestos issues on the Health and Safety Executive (HSE) website covers topics ranging from risk identification and assessment to management, prevention and training. It includes sections explaining the hazards of asbestos, where it can be found in buildings, provides training materials and information on prevention measures. Legal inforamtion is available and explanation of employer duties and role-specific information, e.g. for tradespersons, builders etc. Links to further prublications and case studies as well as videos are listed.

The website provides information and guidance on risk factors for occupational lung disease, how to recognise them and prevent expsoure. There is a tab for Construction, which contains managers toolkits (toolbox talks and visual stands, COSHH guides, site checklists); tools, factsheets and guides; and frequently asked questions.

This Approved Code of Practice (ACOP) and guidance provides practical advice on how to comply with the Dangerous Substances and Explosive Atmospheres Regulations (DSEAR) 2002. These regulations require the risk of fire and explosion from substances connected with work activities to be eliminated or reduced. The ACOP is primarily for an informed and experienced audience, such as health and safety professionals. An additional leaflet for small and medium-sized businesses and on unloading petrol from road tankers as well as links to furhter sources.

This guidance book targets anyone with responsibility for storing dangerous substances, regardless of facility size. It sets out control measures aimed at eliminating or reducing risks to people, at work or otherwise, from the storage of packaged dangerous goods. It contains good practice advice on the design of new facilities (and, within practical limits, of existing sites) and applies in particular to transit/distribution warehouses, open-air compounds and locations generally associated with a chemical production site or end user.

This page provides information for employees on using biological monitoring in relation to chemical exposure. It contains the following sections: What does your employer have to do?, How can chemicals enter your body?, How can the amount of chemicals absorbed into your body be measured?, Why should you take part in a biological monitoring programme?, How should your rights as an individual be protected? and How can you find out more? The answers direct readers to further reading publications.

This guidance document, which primarily targets employers, is an introduction to the design of inhalation exposure monitoring strategies. These procedures can be used to determine employee exposure by inhalation to substances hazardous to health. They will also help in investigating the nature, extent and control of employee exposure. The guidance document helps readers to understand and ask questions about any information or advice they receive from consultants and others.

The leaflet informs about the occurrence of benzene, health effects, prevention measures, health monitoring and the employers obligation regarding their employees working with benzene.

This non-binding guide provides information and examples of good practice in connection with the implementation of safety and health directives, together with other necessary elements such as explanations and practical examples of the hazards and risks associated with all stages of farming, horticulture and forestry work.

This document is intended to provide practical guidance to employers and workers on how the CLP Regulation (Regulation (EC) No 1272/2008 on the Classification, Labelling and Packaging of Substances and Mixtures) will affect the following directives related to the protection of workers: the Chemical Agents Directive (98/24/EC); the Carcinogens and Mutagens Directive (2004/37/EC); the Safety Signs Directive (92/58/EEC); the Pregnant Workers Directive (92/85/EEC); and the Young People at Work Directive (94/33/EC).

The main focus of this guide is to present up-to-date technical and scientific knowledge regarding the prevention of the most significant risks in healthcare, especially biological, musculoskeletal, psychosocial and chemical risks, and to support the implementation of the relevant EU directives in force.